Aoxing Pharmaceutical Stock Forecast, Price & News

+0.00 (+4.44 %)
(As of 09/16/2021 11:19 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume10,000 shs
Average Volume41,572 shs
Market Capitalization$328,154.00
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AOXG News and Ratings via Email

Sign-up to receive the latest news and ratings for Aoxing Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

About Aoxing Pharmaceutical

Aoxing Pharmaceutical Co., Inc. engages in the research, development, manufacture, and distribution of a variety of narcotics and pain management products. It offers prescription and over the counter drugs which include Zhongtong'an, for the indication of oral and dental pain; Yiqi Qiangshen Granule, used to notify and promote blood circulation; and Tilidine Hydrochloride tablets, which orally-absorbs synthetic narcotic analgesic. The company was founded on January 23, 1996 and is headquartered in Foster City, CA.


Aoxing Pharmaceutical Co. Inc.
Aoxing Pharmaceutical Co. Inc.
October 1, 2020 |  wsj.com
Aoxing Pharmaceutical Company, Inc. (AOXG)
Aoxing Pharmaceutical Company, Inc. (AOXG)
March 26, 2020 |  finance.yahoo.com
Aoxing Pharmaceutical Co Inc
Aoxing Pharmaceutical Co Inc
March 19, 2019 |  www.bloomberg.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.05 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Aoxing Pharmaceutical (OTCMKTS:AOXG) Frequently Asked Questions

What stocks does MarketBeat like better than Aoxing Pharmaceutical?

Wall Street analysts have given Aoxing Pharmaceutical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aoxing Pharmaceutical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Aoxing Pharmaceutical?

Aoxing Pharmaceutical saw a decrease in short interest in the month of August. As of August 13th, there was short interest totaling 200 shares, a decrease of 88.9% from the July 29th total of 1,800 shares. Based on an average trading volume of 14,300 shares, the days-to-cover ratio is presently 0.0 days.
View Aoxing Pharmaceutical's Short Interest

How were Aoxing Pharmaceutical's earnings last quarter?

Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) issued its quarterly earnings data on Monday, May, 16th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $6.56 million for the quarter.
View Aoxing Pharmaceutical's earnings history

How has Aoxing Pharmaceutical's stock price been impacted by Coronavirus?

Aoxing Pharmaceutical's stock was trading at $0.0076 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AOXG shares have decreased by 38.2% and is now trading at $0.0047.
View which stocks have been most impacted by COVID-19

Who are Aoxing Pharmaceutical's key executives?

Aoxing Pharmaceutical's management team includes the following people:
  • Zhen Jiang Yue, Chief Executive Officer
  • Gui Rong Zhou, Director-Research & Development
  • Peng Jiang, Director-Sales & Marketing
  • Guo An Zhang, Chief Financial & Accounting Officer, SVP-Finance

Who are some of Aoxing Pharmaceutical's key competitors?

What other stocks do shareholders of Aoxing Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), Spark Networks (LOV), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC), Edap Tms (EDAP), Fortress Biotech (FBIO), Inovio Pharmaceuticals (INO) and Pernix Therapeutics (PTX).

What is Aoxing Pharmaceutical's stock symbol?

Aoxing Pharmaceutical trades on the OTCMKTS under the ticker symbol "AOXG."

How do I buy shares of Aoxing Pharmaceutical?

Shares of AOXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aoxing Pharmaceutical's stock price today?

One share of AOXG stock can currently be purchased for approximately $0.00.

How much money does Aoxing Pharmaceutical make?

Aoxing Pharmaceutical has a market capitalization of $328,154.00.

How many employees does Aoxing Pharmaceutical have?

Aoxing Pharmaceutical employs 346 workers across the globe.

What is Aoxing Pharmaceutical's official website?

The official website for Aoxing Pharmaceutical is axzyen.icm.cn.

Where are Aoxing Pharmaceutical's headquarters?

Aoxing Pharmaceutical is headquartered at FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE, SHIJIAZHUANG CITY F4, 94404.

How can I contact Aoxing Pharmaceutical?

Aoxing Pharmaceutical's mailing address is FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE, SHIJIAZHUANG CITY F4, 94404. The company can be reached via phone at (646) 367-1749 or via email at [email protected]

This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.